Results 51 to 60 of about 148,322 (271)

Catastrophic health expenditure associated with non-inpatient costs among middle-aged and older individuals in China

Frontiers in Public Health
BackgroundSince their establishment, the two predominant social health insurance schemes in China, Urban Employee Medical Insurance (UEMIS) and Urban and Rural Residents’ Medical Insurance (URRMS), have primarily focused on covering non-inpatient ...
Xiaojuan Zhang, Kun Zhu
doaj   +1 more source

“Health inequalities in Armenia - analysis of survey results”

International Journal for Equity in Health, 2012
Introduction Prevailing sociopolitical and economic obstacles have been implicated in the inadequate utilization and delivery of the Armenian health care system. Methods A random survey of 1,000 local residents, from all administrative regions of Armenia,
Tonoyan Tamara, Muradyan Lusine
doaj   +1 more source

Health service use and costs associated with fluoroquinolone‐related tendon injuries

Pharmacology Research & Perspectives, 2021
The aim of this study was to assess costs and health service use associated with tendon injuries after the use of fluoroquinolone antimicrobials in Finland during 2002–2012.
Laura S. M. Kuula, Janne T. Backman, Marja L. Blom   +2 more
doaj   +1 more source

Business As Usual: New Jersey Employers' Experiences with Family Leave Insurance [PDF]

, 2014
This study examines New Jersey employers' experiences with employees who need time off to care for a seriously ill child or family member or to bond with a new baby since 2009, when the state began offering paid family leave through the statewide Family ...
Eileen Appelbaum, Sharon Lerner
core  

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Economic Evidence on Cost Sharing and Alternative Insurance Designs to Address Moral and Behavioral Hazards in High-Income Health Care Systems: A Systematic Review

Journal of Market Access & Health Policy
In health insurance, “moral hazard” describes the concept that coverage without an out-of-pocket cost to consumers could result in health care utilization beyond economically efficient levels.
Marlon Graf, James R. Baumgardner, Ulrich Neumann, Iris P. Brewer, Jacquelyn W. Chou, A. Mark Fendrick   +5 more
doaj   +1 more source

The Impact of Healthcare Spending on Health Outcomes: New Evidence from OECD Countries

Erciyes Medical Journal, 2020
Objective: This study aimed to reveal the impact of the selected healthcare spending indicators on the selected health outcomes for OECD countries.
Sevilay Karaman, Duygu Ürek, İpek Bilgin Demir, Özgür Uğurluoğlu, Oğuz Işık   +4 more
doaj   +1 more source

Demand for Pharmaceuticals: Impacts on Production and Employment in Nearly Every Sector of the Economy [PDF]

The pharmaceutical industry employs around 106 000 people and produces a good 9 billion euros or 2.5% of value added in the manufacturing sector in Germany.
Joachim Schintke, Jörg-Peter Weiss, Stephan Raab   +2 more
core  

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Demand for Pharmaceuticals: Impacts on Production and Employment in Nearly Every Sector of the Economy

, 2005
The pharmaceutical industry employs around 106 000 people and produces a good 9 billion euros or 2.5% of value added in the manufacturing sector in Germany.
Raab, Stephan, Schintke, Joachim, Weiss, Jörg-Peter   +2 more
core